t
On 17 March 2026, Nigel Halkes, a Non-Executive Director of Netcall PLC, purchased 5,000 ordinary shares at a price of 97.45 pence per share on the London Stock Exchange. Following this transaction, Mr. Halkes' total shareholding in Netcall PLC is 10,000 ordinary shares.
| Date | 17 Mar 2026 |
| Time | 17:40:42 |
| Category | Director/PDMR dealings |
| ID | 0345X |
17 March 2026
NETCALL PLC
("Netcall", the "Company" or the "Group")
Director/PDMR Dealing
Netcall plc (AIM: NET), an enterprise software company that unites automation and customer engagement in one AI-powered platform, announces the purchase of 5,000 ordinary shares of 5 pence each ("Ordinary Shares") by Nigel Halkes, Non-Executive Director.
Following the purchase of 5,000 Ordinary Shares, Mr Halkes' shareholding is 10,000 Ordinary Shares.
For further enquiries, please contact:
|
Netcall plc |
Tel. +44 (0) 330 333 6100 |
|
James Ormondroyd, CEO Richard Hughes, CFO Henrik Bang, Non-Executive Chair
|
|
|
Canaccord Genuity Limited (Nominated Adviser and Joint Broker) |
Tel. +44 (0) 20 7523 8000 |
|
Simon Bridges / Harry Gooden / Andrew Potts |
|
|
|
|
|
Singer Capital Markets (Joint Broker) |
Tel. +44 (0) 20 7496 3000 |
|
Charles Leigh-Pemberton / James Moat / Anastassiya Eley |
|
|
|
|
|
Alma Strategic Communications |
Tel. +44 (0) 20 3405 0205 |
|
Caroline Forde / Hilary Buchanan / Emma Thompson |
|
About Netcall
Netcall (AIM: NET) is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 700 organisations across healthcare, government and financial services depend on Netcall for business‑critical workflows, including two‑thirds of NHS Acute Health Trusts, one half of UK local authorities and major enterprises such as Legal & General, Baloise and Santander. For further information, please go to www.netcall.com.
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
Name |
Nigel Halkes |
||||||
|
2. |
Reason for the Notification |
|||||||
|
a) |
Position/status |
Non-Executive Director |
||||||
|
b) |
Initial notification/Amendment |
Initial Notification |
||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
b) |
LEI |
213800GZHEAA98QBJY98 |
||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary Shares |
||||||
|
Identification code |
GB0000060532 |
|||||||
|
b) |
Nature of the transaction |
Purchase of ordinary shares |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information: Aggregated volume Price |
5,000 Ordinary Shares purchased at a price of 97.45 pence per Ordinary Share |
||||||
|
e) |
Date of the transaction |
17 March 2026 |
||||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||||